Skip to content

aTYR PHARMA INC: filings

Every aTYR PHARMA INC annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-07fiscal Q2 202634980001339970-26-000053
10-Q2026-05-15fiscal Q1 202634700001339970-26-000033
10-K2026-03-05fiscal FY 2025401030001339970-26-000008
10-Q2025-11-06fiscal Q3 2025351060001193125-25-269587
10-Q2025-08-07fiscal Q2 2025351020001339970-25-000009
10-Q2025-05-07fiscal Q1 202535720000950170-25-065640
10-K2025-03-13fiscal FY 2024401030000950170-25-038888
10-Q2024-11-07fiscal Q3 2024351060000950170-24-123305
10-Q2024-08-13fiscal Q2 2024351020000950170-24-096185
10-Q2024-05-02fiscal Q1 202435720000950170-24-052092
10-K2024-03-14fiscal FY 2023401030000950170-24-031584
10-Q2023-11-09fiscal Q3 2023351060000950170-23-062058
10-Q2023-08-09fiscal Q2 202334980000950170-23-040598
10-Q2023-05-09fiscal Q1 202334700000950170-23-019686
10-K2023-03-14fiscal FY 2022401030000950170-23-007873
10-Q2022-11-14fiscal Q3 2022331000000950170-22-024724
10-Q2022-08-15fiscal Q2 202233960000950170-22-017401
10-Q2022-05-10fiscal Q1 202229590001564590-22-019293
10-K2022-03-15fiscal FY 202136880001564590-22-010441
10-Q2021-11-12fiscal Q3 202130850001564590-21-056699
10-Q2021-08-11fiscal Q2 202130810001564590-21-043469
10-Q2021-05-14fiscal Q1 202134680001564590-21-028014
10-K2021-03-24fiscal FY 202037900001564590-21-014940
10-Q2020-11-13fiscal Q3 202031890001564590-20-053928
10-Q2020-08-13fiscal Q2 202031850001564590-20-040057
10-Q2020-05-12fiscal Q1 202036720001564590-20-024729
10-K2020-03-26fiscal FY 2019371040001564590-20-013208
10-Q2019-11-14fiscal Q3 201931850001564590-19-043524
10-Q2019-08-14fiscal Q2 201931830001564590-19-032173
10-Q2019-05-14fiscal Q1 201931640001564590-19-019133
10-K2019-03-26fiscal FY 2018341040001564590-19-009381
10-Q2018-11-14fiscal Q3 201828720001564590-18-029559
10-Q2018-08-14fiscal Q2 201828720001564590-18-021715
10-Q2018-05-15fiscal Q1 201824500001564590-18-013628
10-K2018-03-20fiscal FY 201730920001564590-18-006333
10-Q2017-11-14fiscal Q3 201724640001564590-17-023776
10-Q2017-08-14fiscal Q2 201723620001564590-17-017690
10-Q2017-05-11fiscal Q1 201723480001564590-17-010548
10-K2017-03-16fiscal FY 201629880001564590-17-004631
10-Q2016-11-14fiscal Q3 201624650001564590-16-029228
10-Q2016-08-10fiscal Q2 201624650001564590-16-023906
10-Q2016-05-11fiscal Q1 201624500001564590-16-019103
10-K2016-03-30fiscal FY 201528870001564590-16-015652
10-Q2015-11-10fiscal Q3 201526690001564590-15-010357
10-Q2015-08-12fiscal Q2 201526690001193125-15-288119
10-Q2015-06-18fiscal Q1 201524500001193125-15-227340

Inspect the source

Entity
aTYR PHARMA INC / CIK 0001339970
Captured
2026-09-20T07:54:07.036Z
SEC response SHA-256
c3475f065ea6b54c344b2c997462c8932379247c1ed7107b14d14669b6000cf2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001339970.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))